Repligen Q3 Results Top Estimates; Boosts FY23 Earnings Outl

Life sciences company Repligen Corp. (RGEN) announced Tuesday third-quarter net income of $18.17 million or $0.32 per share, sharply down from $40.41 million or $0.

Related Keywords

, Thomson Reuters , Repligen Corp , Repligen , Ife Sciences Company Repligen , Gen ,